Literature DB >> 25692598

Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation.

Balakrishnan S Moorthy1, Hamed Tabatabaei Ghomi2, Markus A Lill2, Elizabeth M Topp3.   

Abstract

A mechanistic understanding of the intermolecular interactions and structural changes during fibrillation is crucial for the design of safe and efficacious glucagon formulations. Amide hydrogen/deuterium exchange with mass spectrometric analysis was used to identify the interactions and amino acids involved in the initial stages of glucagon fibril formation at acidic pH. Kinetic measurements from intrinsic and thioflavin T fluorescence showed sigmoidal behavior. Secondary structural measurement of fibrillating glucagon using far-UV circular dichroism spectroscopy showed changes in structure from random coil → α-helix → β-sheet, with increase in α-helix content during the lag phase followed by increase in β-sheet content during the growth phase. Hydrogen/deuterium exchange with mass spectrometric analysis of fibrillating glucagon suggested that C-terminal residues 22-29 are involved in interactions during the lag phase, during which N-terminal residues 1-6 showed no changes. Molecular dynamics simulations of glucagon fragments showed C-terminal to C-terminal interactions with greater α-helix content for the 20-29 fragment, with hydrophobic and aromatic residues (Phe-22, Trp-25, Val-23, and Met-27) predominantly involved. Overall, the study shows that glucagon interactions during the early phase of fibrillation are mediated through C-terminal residues, which facilitate the formation of α-helix-rich oligomers, which further undergo structural rearrangement and elongation to form β-sheet-rich mature fibrils.
Copyright © 2015 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692598      PMCID: PMC4336368          DOI: 10.1016/j.bpj.2015.01.004

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  58 in total

1.  Immunogenicity and bioactivity of glucagon, modified at methionine-27.

Authors:  W J Nooijen; H J Kempen
Journal:  Horm Metab Res       Date:  1979-08       Impact factor: 2.936

2.  The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting.

Authors:  Jesper Søndergaard Pedersen; Dantcho Dikov; James L Flink; Hans Aage Hjuler; Gunna Christiansen; Daniel Erik Otzen
Journal:  J Mol Biol       Date:  2005-11-09       Impact factor: 5.469

3.  Semi-automated data processing of hydrogen exchange mass spectra using HX-Express.

Authors:  David D Weis; John R Engen; Ignatius J Kass
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-22       Impact factor: 3.109

4.  Glucagon amyloid-like fibril morphology is selected via morphology-dependent growth inhibition.

Authors:  Christian Beyschau Andersen; Daniel Otzen; Gunna Christiansen; Christian Rischel
Journal:  Biochemistry       Date:  2007-05-25       Impact factor: 3.162

5.  Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.

Authors:  Jogender Singh; Jayant B Udgaonkar
Journal:  J Mol Biol       Date:  2013-06-25       Impact factor: 5.469

6.  Assembly of glucagon (proto)fibrils by longitudinal addition of oligomers.

Authors:  Xingfei Zhou; Jingsong Liu; Bin Li; Saju Pillai; Dongdong Lin; Jianhua Liu; Yi Zhang
Journal:  Nanoscale       Date:  2011-07-04       Impact factor: 7.790

7.  Formation and structure of gels and fibrils from glucagon.

Authors:  G H Beaven; W B Gratzer; H G Davies
Journal:  Eur J Biochem       Date:  1969-11

8.  Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation.

Authors:  Ying Zhang; Don L Rempel; Jun Zhang; Anuj K Sharma; Liviu M Mirica; Michael L Gross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 9.  Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure.

Authors:  Indu Kheterpal; Ronald Wetzel
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

10.  Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation.

Authors:  Lise Giehm; Dmitri I Svergun; Daniel E Otzen; Bente Vestergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

View more
  5 in total

1.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

2.  Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use.

Authors:  Nadine Taleb; Adèle Coriati; Christian Khazzaka; Jonathan Bayonne; Virginie Messier; Rémi Rabasa-Lhoret
Journal:  Diabetes Technol Ther       Date:  2017-08-28       Impact factor: 6.118

3.  A Light Activated Glucagon Trimer with Resistance to Fibrillation.

Authors:  Swetha Chintala; Simon H Friedman
Journal:  ACS Biomater Sci Eng       Date:  2021-03-11

4.  The peptide hormone glucagon forms amyloid fibrils with two coexisting β-strand conformations.

Authors:  Martin D Gelenter; Katelyn J Smith; Shu-Yu Liao; Venkata S Mandala; Aurelio J Dregni; Matthew S Lamm; Yu Tian; Wei Xu; Darrin J Pochan; Thomas J Tucker; Yongchao Su; Mei Hong
Journal:  Nat Struct Mol Biol       Date:  2019-06-24       Impact factor: 15.369

5.  Fibrillation of Human Calcitonin and Its Analogs: Effects of Phosphorylation and Disulfide Reduction.

Authors:  Harshil K Renawala; Karthik B Chandrababu; Elizabeth M Topp
Journal:  Biophys J       Date:  2020-11-18       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.